A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
Clinical trial NCT01625260 · TERMINATED
Trial details
- NCT number
- NCT01625260
- Sponsor
- Altor BioScience
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-30
- Primary completion
- 2018-03-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.